Thus, in summary, our results from the present studies demonstrate that AR mediates airway remodeling via PI3K/AKT/GSK3β-PAK pathway and that its inhibition blocks the progression of remodeling in the experimental models of chronic asthma. Here, GSK3B is linked to chronic asthma.